Zankiren
Alternative Names: A 72517Latest Information Update: 22 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Antihypertensives; Heart failure therapies; Piperazines; Thiazoles; Vasodilators
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension